Molecular apocrine tumours in eortc 10994/big 1-00 phase iii study: pathological response after neoadjuvant chemotherapy and clinical outcomes

HIGHLIGHTS

• who: Hervé Bonnefoi from the DepartmentUniversity of Edinburgh, United Kingdom have published the Article: Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes, in the Journal: (JOURNAL) of 13/07/2018
• what: Two frozen biopsies from the primary tumour were mandatory for research purposes. Baseline characteristics and treatment of patients included in this analysis (eligible) and those excluded are presented in Supplementary Table 2 (significant p values below 0.05 are indicated). The study has some strengths and limitations. This study shows that the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.